AQEMIA is a next-gen pharmatech company generating one of the world's fastest-growing drug discovery pipeline. Our mission is to design fast innovative drug candidates for dozens of critical diseases, such as immuno-oncology. The Head of Program Lead will spearhead the development, progress, and alignment of key programs across our organization.
Requirements
- Scientific background PhD (Chemistry, Biology) preferred, MD, PharmD or Engineer
- Consulting background or current experience in lifesciences about asset positioning or R&D portfolio management
- Strong analytical depth and ability to navigate ambiguity
- Excellent leadership and people management capabilities, including experience managing, hiring and developing talent
- Exceptional communication and stakeholder management skills
- Comfortable with uncertainty and able to make strategic decisions in uncertain environments
Benefits
- International Environment: The work language is English
- Prime Location: Based in central Paris and London (King's Cross) with the possibility of 2 remote days per week
- Strong Financial Backing: $100M raised from leading European and International investors
- Expanding Drug Discovery Pipeline: Focused on critical therapeutic areas like Oncology, CNS, Immuno-inflammation... with in vivo proof of concept/patent stage programs
- Collaborations with top Pharma, including a $140M Sanofi deal
- DeepTech Recognition: Part of French Tech 120 and France 2030